Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Buy Stratagene for $246M, CEO Sorge Plans Molecular Dx Spin-Off

NEW YORK (GenomeWeb News) — Agilent Technologies plans to acquire Stratagene for around $246 million in cash, the companies said today.
Separately, Stratagene CEO Joseph Sorge plans to form a new company that will pay $6.6 million for some of Stratagene’s molecular diagnostics assets.
Nick Roelofs, vice president and general manager of Agilent’s Life Sciences Solutions segment, said Stratagene’s products and its experience are “highly complementary to Agilent’s life sciences portfolio,” and said it also was lured by Stratagene’s “excellent presence in important academic and government markets.”
Agilent will pay $10.94 a share for the company, a 28-percent premium above Stratagene’s closing price yesterday of $8.51.
Stratagene said holders of 59 percent of its stock have voted in favor of the deal, and both companies expect the deal to close in around 90 days. The acquisition must still obtain regulatory review and approval from remaining shareholders.
About the new company, which has yet to be named, Sorge said he is "looking forward to having more time to focus on research and discovery and making a difference in human healthcare."

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.